Additional file 4: Table S3. of Metronomic cyclophosphamide activation of anti-tumor immunity: tumor model, mouse host, and drug schedule dependence of gene responses and their upstream regulators

Listing of stringent UPRs induced by CPA treatment in GL261(B6) (Table S3A), LLC (Table S3B), B16F10 (Table S3C), GL261(scid) (Table S3D; CPA/6d treatment), GL261(scid) (Table S3E; CPA/9d treatment), and GL261(scid) tumors (Table S3F; based on genes common to CPA/6d and CPA/9d treatment). (XLSX 287 kb